» Articles » PMID: 31781476

MiR-590-3p and Its Downstream Target Genes in HCC Cell Lines

Overview
Date 2019 Nov 30
PMID 31781476
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs are small non-coding RNA sequences of 18-25 nucleotides. They can regulate different cellular pathways by acting on tumor suppressors, oncogenes, or both. miRNAs are mostly tissue-specific, and their expression varies depending on the cancer or the tissue in which they are found. hsa-miR-590-3p was found to be involved in several types of cancers. In this study, we identified potential downstream target genes of hsa-miR-590-3p computationally. Several bioinformatics tools and more than one approach were used to identify potential downstream target genes of hsa-miR-590-3p. CX3CL1, SOX2, N-cadherin, E-cadherin, and FOXA2 were utilized as potential downstream target genes of hsa-miR-590-3p. SNU449 and HepG2, hepatocellular carcinoma cell lines, were used to carry out various molecular techniques to further validate our results. mRNA and protein expression levels of these genes were detected using RT-PCR and western blotting, respectively. Co-localization of hsa-miR-590-3p and its candidate downstream target gene, SOX2, was carried out using a miRNA in situ hybridization combined with immunohistochemistry staining through anti-SOX2. The results show that there is an inverse correlation between hsa-miR-590-3p expression and SOX2 protein expression in SNU449. Subsequently, we suggest that SOX2 can be a direct downstream target of has-miR-590-3p indicating that it may have a role in the self-renewal and self-maintenance of cancer cells. We also suggest that CX3CL1, E-cadherin, N-cadherin, and FOXA2 show a lot of potential as downstream target genes of hsa-miR-590-3p signifying its role in epithelial-mesenchymal transition. Studying the expression of hsa-miR-590-3p downstream targets can enrich our understanding of the cancer pathogenesis and how it can be used as a therapeutic tool.

Citing Articles

Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches.

Hosseiniyan Khatibi S, Najjarian F, Homaei Rad H, Ardalan M, Teshnehlab M, Zununi Vahed S Sci Rep. 2023; 13(1):3840.

PMID: 36882466 PMC: 9992672. DOI: 10.1038/s41598-023-30720-x.


MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.

Yun J, Ren J, Liu Y, Dai L, Song L, Ma X Bioengineered. 2021; 13(1):634-644.

PMID: 34898373 PMC: 8805927. DOI: 10.1080/21655979.2021.2012548.


EIF5A expression and its role as a potential diagnostic biomarker in hepatocellular carcinoma.

Li L, Li X, Zhang Q, Ye T, Zou S, Yan J J Cancer. 2021; 12(16):4774-4779.

PMID: 34234848 PMC: 8247388. DOI: 10.7150/jca.58168.

References
1.
Wittmann J, Jack H . Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta. 2010; 1806(2):200-7. DOI: 10.1016/j.bbcan.2010.07.002. View

2.
Wong N, Wang X . miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2014; 43(Database issue):D146-52. PMC: 4383922. DOI: 10.1093/nar/gku1104. View

3.
Taylor N, Powell M, Gibb R, Rader J, Huettner P, Thibodeau S . MLH3 mutation in endometrial cancer. Cancer Res. 2006; 66(15):7502-8. DOI: 10.1158/0008-5472.CAN-06-0248. View

4.
Kim M, Jeong E, Ahn C, Kim S, Lee S, Yoo N . Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol. 2008; 39(7):1059-63. DOI: 10.1016/j.humpath.2007.11.013. View

5.
Wang X . Improving microRNA target prediction by modeling with unambiguously identified microRNA-target pairs from CLIP-ligation studies. Bioinformatics. 2016; 32(9):1316-22. PMC: 6169475. DOI: 10.1093/bioinformatics/btw002. View